Brief: Polaryx Therapeutics Selects Contract Research Organization For Soteria Phase 2 Basket Trial
17/02/2026 13:42
Feb 17 (Reuters) - Polaryx Therapeutics Inc PLYX.O: POLARYX THERAPEUTICS SELECTS CONTRACT RESEARCH ORGANIZATION FOR SOTERIA PHASE 2 BASKET TRIAL POLARYX THERAPEUTICS INC: CONTINUES TO ACTIVELY WORK WITH ITS CONTRACT RESEARCH ORGANIZATION (CRO) TO INITIATE TRIAL IN FIRST HALF OF 2026 Source text: ID:nGNE9RWxdW Further company coverage: PLYX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Polaryx Therapeutics
See all newsBrief: Polaryx Therapeutics Closes $10 Million Private Placement Equity Financing
U.S. STOCKS ON THE MOVE-Northern Trust, UnitedHealth, Tractor Supply
U.S. STOCKS ON THE MOVE-Intel, Teradyne, MSCI
Polaryx rises after FDA grants fast-track status for rare disease drug
Brief: Polaryx Therapeutics Receives U.S. FDA Fast Track Designations For All Four Indications To Be Evaluated In The Soteria Basket Trial